Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Wright Reports
Provider: Reuters Investment Profile
Provider: GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

MedX Health Corp announces CE mark for molemate/simsys skin cancer imaging systems

Wednesday, 12 Feb 2014 11:49am EST 

MedX Health Corp:Says receipt of a CE Mark from Conformite Europeenne, which allows the company to market its MoleMate and SIMSYS systems in Europe to dermatologists and to expand further its pharmacy-based sales channel. 

Company Quote

-0.0050 -6.67%
31 Oct 2014